Regulatory and Standard Setting Organizations

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-15-2020
Volume 2020 eBook
Issue 3
Pages: 73-76

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

Connect with pharmaceutical and healthcare regulatory authorities around the world via this directory.

Access these resources in Pharmaceutical Technology's October 2020 Regulatory Sourcebook. ​

Articles in this issue
Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms: Part 1
Enhancing Process Validation for Sterile Liquid and Freeze-Dried Forms: Part 1
Enhancing Process Validation for Solid Oral Dosage Forms: Part 2
Enhancing Process Validation for Solid Oral Dosage Forms: Part 2
Due diligence
Due Diligence Assessment of CMC Activities
Do Pharmacopoeias Inadvertently Facilitate Data Integrity Violations?
Do Pharmacopoeias Inadvertently Facilitate Data Integrity Violations?
Tackling Cybersecurity Challenges in Legacy Systems
Tackling Cybersecurity Challenges in Legacy Systems
POLINA - STOCK.ADOBE.COM
Ending ‘Magical Thinking’ in Compounding
luchschenF - Stock.adobe.com
Viral Vector API Characterization of Product-Related Impurities
TEX VECTOR - STOCK.ADOBE.COM
Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation
Strong Quality Culture: A How-To for Busy Managers
Strong Quality Culture: A How-To for Busy Managers
tashatuvango - Stock.adobe.com
Resources, Guidelines, and Guidance Documents
Regulatory and Standard Setting Organizations
Regulatory and Standard Setting Organizations
Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Industry Outlook 2025: US Political Motivations and Legislative Discussions
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Industry Outlook 2025: Consolidating Data and Relaxing Regulations on AI
Sustainability in Pharmaceutical Manufacturing
Sustainability in Pharmaceutical Manufacturing
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Using Continuous Processes and Automation to Remove Contamination Risk
AAPS PharmSci 360 2024: How AI is Helping to Ensure Companies’ GMP Health
AAPS PharmSci 360 2024: How AI is Helping to Ensure Companies’ GMP Health
CPHI Milan 2024: Pharma Developments in Emerging Markets
CPHI Milan 2024: Pharma Developments in Emerging Markets
CPHI Milan 2024: Evolution of Aseptic Processing Equipment for Regulatory Compliance
CPHI Milan 2024: Evolution of Aseptic Processing Equipment for Regulatory Compliance
Purna Thakker, founder and CEO of ADPT Solution.
Interpreting Regulations and Meeting FDA Requirements at CPHI North America
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Susan Schniepp of Regulatory Compliance Associates Explores the Impact of QMS on Quality Maturity (INTERPHEX 2024)
Europa Perspectives Interview with Alexander Natz
Europa Perspectives on Lifecycle Management
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

EMA Recommends Five New Medicines for Approval

Patrick Lavery
March 28th 2025
Article

Three of the five are biosimilars, and seven additional medicines received recommendations for indication extensions.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

FDA Approves Novartis Oral Treatment for Adults with C3 Glomerulopathy

Patrick Lavery
March 25th 2025
Article

Fabhalta (iptacopan) received a positive opinion for treatment of C3G from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) and has been approved twice before by FDA.

Drug Solutions Podcast: Innovations and Advances in Drug Dosage Forms

Drug Solutions Podcast: Innovations and Advances in Drug Dosage Forms

Felicity Thomas
August 1st 2023
Podcast

In this episode, David Tisi and Reenal Gandhi provide expert insights into advances and innovations changing the drug dosage form landscape.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Recommends Four Medicines for Approval in February

Susan Haigney
February 28th 2025
Article

Treatments for autoimmune diseases, multiple cancers, and skin blistering have been recommended for marketing approval.

Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - © Artur - stock.adobe.com

EMA Earns EMAS Certification

Susan Haigney
February 17th 2025
Article

The agency has received certification with the Eco-Management and Audit Scheme for its commitment to environmental sustainability.